Doranidazole

多拉达唑

Report date: 2025/02/17 14:51:25
NME

Base Information

Drug NameDoranidazole
Drug Alias NamedoranidazolumdoranidazoledoranidazolPR-350RP-343 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRadiosensitizers
TargetsNot applicable
Therapy Area/IndicationsLung NeoplasmsHead and Neck NeoplasmsPancreatic Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (NDA/BLA)
Highest Status in ChinaPending
Originator CompaniesShenzhen Main Luck Pharmaceuticals IncPola Chemical
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesN/A
Inactive CompaniesPola ChemicalShenzhen Main Luck Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsLung NeoplasmsHead and Neck NeoplasmsPancreatic Neoplasms +[4] 

Other Information

ATC CodeN/A
Related LinksKEGG